Navigation Links
Erectile Dysfunction More Common in Men Who Regularly Take Prescription Painkillers

PORTLAND, Ore., May 15, 2013 /PRNewswire/ -- Regularly taking prescription painkillers, also known as opioids, is associated with a higher risk of erectile dysfunction, according to a study published online today in the journal Spine.

The researchers included more than 11,000 men with back pain in the study and examined their health records to find out if the men taking prescription painkillers were more likely to also receive prescriptions for testosterone replacement or ED medications.  

More than 19 percent of men who took high-dose opioids for at least four months also received ED prescriptions, while fewer than 7 percent of men who did not take opioids received ED prescriptions.

In the study, men over 60 were much more likely to receive ED prescriptions, but even after researchers adjusted for age and other factors, men taking high-dose opioids were still 50 percent more likely to receive ED prescriptions than men who did not take prescription painkillers.

"Men who take opioid pain medications for an extended period of time have the highest risk of ED," said study lead author Richard A. Deyo , MD, MPH, investigator with the Kaiser Permanente Center for Health Research and professor of Evidence-based Family Medicine at Oregon Health & Science University.

"This doesn't mean that these medications cause ED, but the association is something patients and clinicians should be aware of when deciding if opioids should be used to treat back pain," Dr. Deyo added.

Opioid use is growing in the U.S. According to the Centers for Disease Control and Prevention's Mortality and Morbidity Report, prescription opioid sales quadrupled between 1999 and 2010. Another recent survey, published in the journal Pain, estimates 4.3 million adults in the U.S. use these opioid medications on a regular basis.  The most commonly used prescription opioids are hydrocodone, oxycodone and morphine.

"There is no question that for some patients opioid use is appropriate, but there is also increasing evidence that long-term use can lead to addiction, fatal overdoses, sleep apnea, falls in the elderly, reduced hormone production, and now erectile dysfunction," says Dr. Deyo, who has spent more than 30 years studying treatments for back pain.

For this study, Dr. Deyo and colleagues identified 11,327 men in Oregon and Washington enrolled in the Kaiser Permanente health plan who visited their doctors for back pain during 2004. The researchers examined the men's pharmacy records for six months before and after the back-pain visit to find out if they had filled prescriptions for opioids and for ED medications or testosterone replacement.

Opioid use was categorized as "none" for men who did not receive a prescription for opioids; "acute" for men who took opioids for three months or less; "episodic" for men who took opioids for more than three months, but less than four months and with fewer than 10 refills; and "long-term" for men who took opioids (a) for at least four months or (b) for more than three months with 10 or more refills. Anything more than 120 mg of morphine equivalent was categorized as high-dose use.

More than 19 percent of the men who took high-dose opioids for at least four months also received ED medications or testosterone replacement. More than 12 percent of men who took low-dose opioids (under 120 mg) for at least four months also received ED medications or testosterone replacement. Fewer than 7 percent of men who didn't take opioids received ED medications or testosterone replacement.

Researchers found that age was the factor most significantly associated with receiving ED prescriptions. Men 60 to 69 were 14 times more likely to receive prescriptions for ED medication than men 18 to 29.

Depression, other health conditions (besides back pain), and use of sedative hypnotics like benzodiazepines also increased the likelihood that men would receive ED prescriptions.

But even after researchers adjusted for these factors, long-term opioid use increased the likelihood of also receiving prescriptions for ED medication by 50 percent.

This study was made possible in part by Kaiser Permanente's comprehensive electronic health record system, one of the largest private systems in the world. The organization's integrated model and electronic health record system securely connects 9.1 million people, 611 medical offices and 37 hospitals, linking patients with their health care teams, their personal health information and the latest medical knowledge. The system coordinates patient care between the physician's office, the hospital, radiology, the laboratory and the pharmacy, and helps eliminate the pitfalls of incomplete, missing, or unreadable charts. It also connects Kaiser Permanente's researchers to one of the most extensive collections of longitudinal medical data available, facilitating studies and important medical discoveries that shape the future of health and care delivery for patients and the medical community.

Study authors include Richard A. Deyo , MD, MPH, from the Kaiser Permanente Center for Health Research and Oregon Health & Science University; David Smith , RPh, PhD,  Eric S. Johnson , PhD, Xiuhai Yang , MS, and Amanda Petrik , MS, from the Kaiser Permanente Center for Health Research; Carrie J. Tillotson , MPH, from Oregon Health & Science University; Benjamin J. Morasco , PhD, and Steven K. Dobscha , MD, from Oregon Health & Science University and the Veterans Administration Medical Center in Portland, Ore.; and Marilee Donovan RN , PhD, from Kaiser Permanente Northwest in Portland, Ore.

About the Kaiser Permanente Center for Health Research
The Kaiser Permanente Center for Health Research, founded in 1964, is a nonprofit research institution dedicated to advancing knowledge to improve health. It has research sites in Portland, Ore., Honolulu, and Atlanta.

About Kaiser Permanente
Kaiser Permanente is committed to helping shape the future of health care. We are recognized as one of America's leading health care providers and nonprofit health plans. Founded in 1945, our mission is to provide high-quality, affordable health care services and to improve the health of our members and the communities we serve. We currently serve 9.1 million members in nine states and the District of Columbia. Care for members and patients is focused on their total health and guided by their personal physicians, specialists and team of caregivers. Our expert and caring medical teams are empowered and supported by industry-leading technology advances and tools for health promotion, disease prevention, state-of-the-art care delivery and world-class chronic disease management. Kaiser Permanente is dedicated to care innovations, clinical research, health education and the support of community health. For more information, go to:

For more information:
Catherine Hylas Saunders,, 202.585.2603
Mary Sawyers ,, 503.335.6602

SOURCE Kaiser Permanente
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Increased Dosage of Needle-Free Erectile Dysfunction Medication TriMix-gel Now Available through KRS Global Biotechnology
2. Fight Erectile Dysfunction the Safe and Healthy Way with Function for Men
3. Testosterone Therapy: A Misguided Approach to Erectile Dysfunction (ED)
4. A Novel Oral Anticoagulant is Planned to be Developed for Patients with Prosthetic Heart Valves or Chronic Renal Dysfunction
5. Palatin Technologies Announces Last Patient Completed Treatment In Phase 2B Bremelanotide Female Sexual Dysfunction Trial
6. Omeros Announces $16.2 Million Registered Direct Offering of Common Stock
7. Isis Pharmaceuticals Announces Proposed Public Offering of Common Stock
8. InspireMD Announces Pricing of Underwritten Public Offering of Common Stock and Listing on NYSE MKT
9. MEI Pharma Announces $15.2 Million Registered Offering Of Common Stock
10. Vasomedical Announces Share Repurchase Program of up to $1.5 Million in Common Stock
11. Safe in Common to Exhibit at 61st Annual National Student Nurses Association Conference
Post Your Comments:
(Date:11/25/2015)... 2015 Kitov Pharma ceuticals ... a biopharmaceutical company focused on the development of therapeutic ... today announced the closing of its previously announced underwritten ... ), each representing 20 ordinary shares of the Company, ... ADSs and warrants were issued in a fixed combination ...
(Date:11/25/2015)...  Today AVACEN Medical announced the issue of United States patent No. ... ". This patent shields the company,s AVACEN 100 dry heat therapy medical device and specific methods ... Photo - ... ... ...
(Date:11/25/2015)... , Nov. 25, 2015 USP 800 ... drug preparations (e.g. pharmacists, pharmacy technicians, nurses, physicians, ... technicians). The chapter also covers all entities which ... pharmacies, hospitals, other healthcare institutions, patient treatment clinics, ... --> --> What is ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... November 25, 2015 , ... For the first time, Vitalalert ... Organizations, One Beat ” campaign. The partnership between the two groups began in 2014 ... MAP International’s cause. , MAP International was founded in 1954 and is an international ...
(Date:11/25/2015)... ... ... On November 25, 2015, officials of Narconon Arrowhead , the drug rehabilitation ... new cutting edge recovery program that has been 50 years in the making. ... with the purpose to free addicts from the symptoms and negative behaviors of addiction. ...
(Date:11/25/2015)... ... ... Smiles by Stevens is pleased to announce the addition of Botox® for ... aware of the benefits of Botox® in the treatment of moderate facial wrinkling, few ... and pain as a result of Jaw Tension, TMJ (temporo-mandibular joint) disorder, and Bruxism ...
(Date:11/25/2015)... ... November 25, 2015 , ... In an ongoing Clinical Study conducted by an ... IL, UV Angel is evaluating the efficacy of its product and its disinfection protocol. ... 30 beds) from May 2014 through October 2015 at a 360-bed, acute-care, academic medical ...
(Date:11/25/2015)... Spring, Md (PRWEB) , ... November 25, 2015 ... ... Pulmonary Hypertension Association (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups responsible ... history of this disease. The Periwinkle Pioneers, nominated by the public, will receive ...
Breaking Medicine News(10 mins):